Atomo Diagnostics Joins With Access Bio To Globalize HIV POC Testing
Executive Summary
Australian firm Atomo Diagnostics and US-based Access Bio have joined forces to expand point-of-care HIV testing into markets beyond their domestic borders. Under the agreement, Access Bio will add Atomo's all-in-one rapid HIV diagnostic test to its infectious disease portfolio and market it to the professional-use segment.